| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |